Publication | Open Access
Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non–Small-Cell Lung Cancer
330
Citations
26
References
2010
Year
IPI-504 has clinical activity in patients with NSCLC, particularly among patients with ALK rearrangements.
| Year | Citations | |
|---|---|---|
Page 1
Page 1